Nuclear factor kappa B (NFKB) is a transcription factor that is activated in many different cell types. In response to viruses, bacteria and stress factors as well as phorbol esters and inflammatory cytokines such as interleukin 1 (ILl), NFKB becomes activated [I]. It regulates the expression of various genes involved in the immune and inflammatory response, including the genes for cytokines, cell surface receptors, adhesion molecules and acute phase proteins. Although there is no clear concensus on the events leading to NFKB activation, a model has been proposed based on evidence to date. NFKB is located in the cytoplasm of resting cells in an inactive state complexed with the inhibitor protein, IKB. Upon stimulation the IKB protein becomes phosphorylated and dissociates from the complex. The now active NFKB complex can then translocate to the nucleus where it binds to the K B concensus sequence and causes a change in gene expression. Evidence for the involvement of protein kinases and protein phosphatases in this process comes from the inducing effect of the protein kinase C activator, phorbol myristate acetate (PMA) [2] and the protein phosphatase inhibitor, okadaic acid [3] , and from the inhibiting effect of the tyrosine kinase inhibitor, herbimycin A 141.
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ILl and PMA both activate NFKB and induce IL2 production in the murine thymoma cell line, EL4.NOBl. In our study we probed the importance of phosphorylation in the signal transduction pathway leading to these responses using a range of protein kinase inhibitors. Following stimulation , cells were fractionated and nuclear extracts were prepared using the method as outlined [5] . These nuclear extracts were incubated with [32-PI labelled DNA containing the NFKB concensus sequence and analysed for NFKB binding activity by electromobility shift assay as described [2]. NFKB present in the nuclear extract binds to the labelled DNA probe causing it to retard in a 5% polyacrylamide gel, while unbound or free probe migrates to the bottom of the gel.
Following electrophoresis, gels were dned and autoradiographed.
IL2 produced by EL4 cells in response to stimulus was measured using an enzyme-linked immunosorbant assay (ELISA).
Initially we looked at the effect of staurosporine, a potent PKC inhibitor, on NFKB activation and IL2 production. As expected, staurosporine inhibited both PMA activation of NFKB and PMA induction of IL2. Interestingly, while having no effect on Linduced NFKB staurosporine significantly enhanced ILl -stimulated IL2 production. Staurosporine had little effect on IL2 production on its own. Table 1 summarise the effect of the protein kinase inhibitors on 1LI-and PMA-stimulated IL2 production respectively. Quercetin, a compound recently shown to inhibit ILI-activated MAP kinase [6] , had no effect on NFKB activation by either stimulus, but significantly inhibited PMA-induced 1L2 with little effect against ILl. We used 2 tyrosine kinase inhibitors, genistein, which acts as a competitive inhibitor for ATP 171 and herbimycin A, which covalently modifies thiol groups on tyosine kinases [XI.
Genistein had no effect on either response to the 2 stimuli. In agreement with Iwasaki ef d., 1992 [4] , we found that herbimycin A blocked IL1 activation of NFKE (Figure 1 ). However this group found that herbimycin A had no effect on PMA-induced NFKB i n 702/3 cells. This did not appear to be the case with PMAstimulated EL4 cells ( Figure I ). This compound also caused a significant inhibition of IL1-and PMA-induced IL2. As herbimycin A reacts with thiols, we also determined the effect of another thiol modifying compound, diamide. Like herbimycin A, diamide, at concentrations ranging from 100 -5OOpM, inhibited the activation of NFKB by L l (not shown).
These studies therefore provide initial suggestions that MAP kinase, whilst not being involved in NFKB activation, is likely to be important for PMA-induced IL2 rather than that induced by IL1. The results also suggest that a redox-sensitive protein thiol, possibly on a tyrosine kinase, may be important for activation of NFKB and induction of IL2 by both ILl and PMA.
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